Aarti Drugs Limited

BSE:524348 Stock Report

Market Cap: ₹41.9b

Aarti Drugs Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Prakash Patil

Chief executive officer

₹27.8m

Total compensation

CEO salary percentage41.5%
CEO tenure40yrs
CEO ownership9.6%
Management average tenure11.4yrs
Board average tenure8.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Prakash Patil's remuneration changed compared to Aarti Drugs's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹2b

Jun 30 2024n/an/a

₹2b

Mar 31 2024₹28m₹12m

₹2b

Dec 31 2023n/an/a

₹2b

Sep 30 2023n/an/a

₹2b

Jun 30 2023n/an/a

₹2b

Mar 31 2023₹28m₹11m

₹2b

Dec 31 2022n/an/a

₹2b

Sep 30 2022n/an/a

₹2b

Jun 30 2022n/an/a

₹2b

Mar 31 2022₹31m₹10m

₹2b

Dec 31 2021n/an/a

₹2b

Sep 30 2021n/an/a

₹2b

Jun 30 2021n/an/a

₹2b

Mar 31 2021₹35m₹8m

₹3b

Dec 31 2020n/an/a

₹3b

Sep 30 2020n/an/a

₹2b

Jun 30 2020n/an/a

₹2b

Mar 31 2020₹19m₹7m

₹1b

Dec 31 2019n/an/a

₹1b

Sep 30 2019n/an/a

₹1b

Jun 30 2019n/an/a

₹888m

Mar 31 2019₹15m₹7m

₹898m

Dec 31 2018n/an/a

₹863m

Sep 30 2018n/an/a

₹887m

Jun 30 2018n/an/a

₹943m

Mar 31 2018₹14m₹7m

₹823m

Compensation vs Market: Prakash's total compensation ($USD324.79K) is about average for companies of similar size in the Indian market ($USD263.12K).

Compensation vs Earnings: Prakash's compensation has been consistent with company performance over the past year.

CEO

Prakash Patil (77 yo)

40yrs

Tenure

₹27,848,000

Compensation

Mr. Prakash Moreshwar Patil has been the Chairman of the Board of Aarti Drugs Limited since April 2014. Mr. Patil has been the Managing Director of Aarti Drugs Limited since June 1, 2007 and serves as its...

Leadership Team

NamePositionTenureCompensationOwnership
Prakash Patil
Chairmanno data₹27.85m9.59%
₹ 4.0b
Harshit Savla
Joint MD & Executive Director21.8yrs₹25.54m4.71%
₹ 2.0b
Adhish Patil
CFO & COO12.5yrs₹11.44m1.23%
₹ 516.1m
Rushikesh Deole
Company Secretary & Compliance Officer5.8yrs₹1.17mno data
Harit Shah
Whole-Time Directorno data₹25.54m4.43%
₹ 1.9b
Uday Patil
Whole-Time Director24.3yrs₹3.35m0.055%
₹ 22.9m
Rashesh Gogri
MD & Executive Director10.3yrs₹25.54m4.61%
₹ 1.9b
Dhanaji Kakade
Vice President of Technicalno datano datano data
Vishwa Savla
Managing Director of the Pinnacle Life Science Private Limitedless than a yearno data1.02%
₹ 428.4m

11.4yrs

Average Tenure

61yo

Average Age

Experienced Management: 524348's management team is seasoned and experienced (11.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Prakash Patil
Chairman40yrs₹27.85m9.59%
₹ 4.0b
Harshit Savla
Joint MD & Executive Director38yrs₹25.54m4.71%
₹ 2.0b
Harit Shah
Whole-Time Director29.3yrs₹25.54m4.43%
₹ 1.9b
Uday Patil
Whole-Time Director24.3yrs₹3.35m0.055%
₹ 22.9m
Rashesh Gogri
MD & Executive Director12.4yrs₹25.54m4.61%
₹ 1.9b
Chandrakant Gogri
Chairman Emeritus12.4yrs₹43.00k1.86%
₹ 779.4m
Neha Gada
Independent Director2.7yrs₹155.00kno data
Sandeep Joshi
Additional Independent Directorless than a yearno datano data
Narendra Salvi
Non-Executive Director4.4yrs₹100.00kno data
Ankit Paleja
Independent Director3.3yrs₹215.00kno data
Bhaskar Thorat
Independent Director2.7yrs₹155.00kno data
Hasmukh Dedhia
Additional Independent Directorless than a yearno datano data

8.4yrs

Average Tenure

61yo

Average Age

Experienced Board: 524348's board of directors are considered experienced (8.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 03:39
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aarti Drugs Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rashmi Sancheti ShettyCGS International
Rashmi Sancheti ShettyDolat Capital Market Pvt. Ltd.
Kameswari V. S. ChavaliFirstCall Research